Pricing as low as $350/mo
What is Semaglutide?
Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study semaglutide exclusively for weight loss. A series of clinical trials known as the STEP clinical trials demonstrated that almost 90% of patients lost 5% or more of their body weight. There is no other weight loss drug on the market that compares. In June of 2022, the FDA approved semaglutide for weight loss.
What is Tirzepatide?
Tirzepatide is a prescription medication used for weight loss and the treatment of type 2 diabetes. It’s the active ingredient in brand names like Mounjaro® (FDA-approved for type 2 diabetes) and Zepbound™ (FDA-approved for weight loss). Tirzepatide is part of a class of medications known as incretin mimetics.
What are the Differences between Semaglutide & Tirzepatide?
Tirzepatide and semaglutide are both weekly injectable medications used for weight loss and type 2 diabetes, but they work in slightly different ways. Semaglutide targets a single hormone (GLP-1) to reduce appetite and improve blood sugar control, while tirzepatide targets two hormones (GLP-1 and GIP), leading to greater appetite suppression and enhanced weight loss. Clinical studies have shown that tirzepatide often results in more significant weight loss than semaglutide. While both have similar side effects—like nausea and digestive issues—tirzepatide may cause slightly more gastrointestinal discomfort at higher doses.
How do they work?
Semaglutide acts like GLP-1 (a gut hormone) to:
-
Increase insulin production
-
Decrease glucagon synthesis
-
Delay gastric emptying
-
Suppress hunger. It signals your brain that you are full so you can loose weight without feeling like you are depriving yourself.
What are the benefits?
-
Lower blood sugar, reduce body weight, and lower the risk of cardiovascular events—like heart attack, stroke, or heart disease—in millions of patients.
-
Many patients lose 1-3 pounds a week.
-
Many patients appreciate the convenience of one weekly injection.
What are common side effects?
-
Commonly reported GI side effects - nausea, vomiting, diarrhea, constipation, abdominal pain
-
Site reactions
-
Fatigue
-
Headaches
Who is NOT a candidate?
-
​Pregnant or breastfeeding
-
Allergic to GLP-1 medications or any of their components
-
Personal or family history of medullary thyroid carcinoma
-
History of multiple endocrine neoplasia syndrome type 2 (MEN2)
-
History of pancreatitis
-
End stage renal disease (on dialysis)
-
BMI<25
-
Patients diagnosed with diabetes that are taking insulin or a sulfonylurea
Who IS a candidate?
Everyone else*
​
*Health history, medications and BMI information will be carefully reviewed by a licensed provider to determine each candidate’s eligibility.
What do we charge?
$350 per month for Semaglutide
$375 per month for Tier 1 Tirzepatide (lower beginning dose)
$575 per month for Tier 2 Tirzepatide (higher established dose)
*Some patients never leave Tier 1. We work with you to find the right dose for you.
If another clinic charges less than we do, then they are almost certainly under dosing or "micro dosing"; an unproven and inferior method of treatment.
​
*Medication is mailed directly to you from our United States based pharmacy
